Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 30:15:100527.
doi: 10.1016/j.ajpc.2023.100527. eCollection 2023 Sep.

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention

Arielle Abovich  1 , Daniel S Matasic  2 , Rhanderson Cardoso  1 , Chiadi E Ndumele  2 , Roger S Blumenthal  2 , Ron Blankstein  1 , Martha Gulati  3
Affiliations
Review

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention

Arielle Abovich et al. Am J Prev Cardiol. .

Abstract

The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of established HF risk factors, such as hypertension, diabetes, and obesity. Many individuals have multiple risk factors, placing them at even higher risk. In addition, these risk factors disproportionately impact various racial and ethnic groups. Recognizing the rising health and economic burden of HF in the U.S., the 2022 American Heart Association / American College of Cardiology / Heart Failure Society of America (AHA/ACC/HFSA) Heart Failure Guideline placed a strong emphasis on prevention of HF. The purpose of this review is to highlight the role of both primary and secondary prevention in HF, as outlined by the recent guideline, and address the role of the preventive cardiology community in reducing the prevalence of HF in at-risk individuals.

Keywords: Guideline; Heart failure; Prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Roger S. Blumenthal reports a relationship with Amgen Inc that includes: funding grants. Roger S. Blumenthal reports a relationship with Novartis that includes: funding grants. Martha Gulati reports a relationship with Novartis that includes: board membership. Martha Gulati reports a relationship with Siemens Healthcare Diagnostics Inc that includes: speaking and lecture fees. Martha Gulati is a co-investigator and site PI of the Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Study funded by the Department of Defense, and a co-investigator of the Women Ischemic Syndrome Evaluation (WISE) Study funded by the NHLBI

Figures

Fig. 1
Fig. 1
Guideline Approach for Prevention of Heart Failure for At-Risk Patients (Stage A). The 2022 AHA/ACC/HFSA Heart Failure Guidelines highlight heart failure prevention by (1) identifying patients at-risk for heart failure with comorbidities and screening measures, and (2) Optimizing Blood Pressure, Diabetes, and Lifestyle in patients at-risk.
Fig. 2
Fig. 2
Guideline Approach for Management of Pre-Heart Failure (Stage B). The 2022 AHA/ACC/HFSA Heart Failure Guidelines highlight management of Pre-Heart Failure by continued optimizing Blood Pressure, Diabetes, and Lifestyle with the addition of ACEi and Beta Blockers with patients with reduced Left Ventricular Ejection Fraction (LVEF) and high-intensity statin with patients with history of myocardial infarction and/or acute coronary syndrome (ACS).
Central Illustration
Central Illustration
The 2022 AHA/ACC/HFSA Heart Failure Guidelines emphasizes Heart Failure Prevention for individuals at-risk for Heart Failure (ACC/AHA Stage A) and for individuals with Pre-Heart Failure (ACC/AHA Stage B).
See this image and copyright information in PMC

References

    1. Tsao C.W., Aday A.W., Almarzooq Z.I., et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation. 2022;145:e153–e639. - PubMed
    1. Tsao C.W., Lyass A., Enserro D., et al. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC: Heart Failure. 2018;6:678–685. - PMC - PubMed
    1. Watson M., Dardari Z., Kianoush S., et al. Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis) The American Journal of Cardiology. 2019;123:1972–1977. - PMC - PubMed
    1. Hamo C.E., Kwak L., Wang D., et al. Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. Journal of the American Heart Association. 2022;11 - PMC - PubMed
    1. CDC WONDER. Multiple Cause of Death, 1999-2020 Request Form Accessed June 5, 2022. https://wonder.cdc.gov/controller/datarequest/D77.